Semi-automatic analysis of the reaction results by the Reader with the possibility of remote consultation. Low cost of the analysis in comparison with ICC. Affordable even for hospitals.
The technology for production of biochip-based test systems for a cytologic analysis is protected by patents in Russia and abroad. The test systems are certificated and designed for in vitro studies in clinical and diagnostic laboratories of medical and preventive treatment facilities and educational institutions, as well as in medical biochemistry and scientific and research practice. The development has no direct analogy in the world. Among all well-known tools used in diagnosis of malignant tumours, biochip-based tests systems for cytologic studies can boast the lowest cost and at the same time great information contents and clinical relevance of the obtained results.